News
Canada has approved Novo Nordisk's diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of ...
Canada's health regulator has approved Novo Nordisk's diabetes drug, Ozempic, for reducing the risk of kidney failure and ...
Diabetic medicine Ozempic now approved by Health Canada to reduce the risk of further kidney decline among patients with Type ...
The Canadian Press on MSN14h
Health Canada approves Ozempic for kidney protection in Type 2 diabetics
Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes. Between ...
Health Canada approved Ozempic for type 2 diabetes patients with chronic kidney disease after positive FLOW trial results.
Health Canada has approved Ozempic in an effort to help reduce the risk of kidney decline for patients living with Type 2 ...
The Canadian Press on MSN6h
Quebec City using artificial intelligence to manage traffic, reduce congestion
According to Google Canada, Quebec City is the first municipality in the country to partner with the web giant's Green Light ...
The law gives Quebec's labour minister the power to end a labour dispute by imposing arbitration when the strike or lockout is deemed likely to cause serious harm to the public.
Novo Nordisk announced today that Ozempic® (semaglutide injection) is now approved as the first-and-only medication indicated for both the once-weekly ...
8h
Asianet Newsable on MSNHealth Canada Approves Novo’s Ozempic to Reduce Risk Of Kidney Function Decline, Cardiovascular Death
The approval from Health Canada for the indications is based on the results of a trial in which Semaglutide 1 mg demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results